The cardiovascular monitoring and diagnostic devices market is witnessing strong growth in North America, owing to the increasing prevalence of cardiovascular diseases in the region. According to the Centers for Disease Control and Prevention (CDC), one person dies every 36 seconds from cardiovascular disease in the United States. Around 655,000 people (one in every four) in the U.S. die from heart disease each year. Cardiovascular disease is the leading cause of death for men, women, and people of most racial and ethnic groups in the United States. Thus, there is an increasing demand for cardiovascular monitoring and diagnostic devices in North America, especially in the United States.
In February 2021, RhythMedix launched its next-generation RhythmStar wearable device with built-in 4G cellular connectivity. The technology enables rapid ECG analysis and reporting of cardiac abnormalities by RhythMedix's team of U.S.-based certified technicians, who alert physicians if an arrhythmia of concern is detected. Cardiovascular monitoring and diagnostic devices, such as event monitoring devices, ECG stress testing, Holter monitoring device, and ECG monitoring device, are used to monitor heart patients who are suffering from different cardiovascular diseases. Increasing approvals and launches of new devices is also driving the cardiovascular monitoring and diagnostic devices market.
Read More : https://bit.ly/3wBl4jQ
